Background:Current critical care pharmacist (CCP) practices and perceptions related to neuromuscular infusion (NMBI) use for acute respiratory distress syndrome (ARDS) maybe different with the COVID-19 pandemic and the publication of 2020 NMBI practice ...
Devlin, J. W., Train, S. E., Burns, K. E. A., Massaro, A., Wu, T. T., Castor, T., Vassaur, J., Selvan, K., Kress, J. P. & Erstad, B. L., Nov 2023, In: Annals of Pharmacotherapy.57, 11, p. 1282-12909 p.
Research output: Contribution to journal › Article › peer-review
Devlin, J. W. (Creator), Train, S. E. (Creator), Massaro, A. (Creator), Wu, T. T. (Creator), Castor, T. (Creator), Vassaur, J. (Creator), Selvan, K. (Creator), Kress, J. P. (Creator), Erstad, B. L. (Creator) (2023). Critical Care Pharmacist Attitudes and Perceptions of Neuromuscular Blocker Infusions in ARDS. SAGE Journals. 10.25384/sage.c.6481528.v1